The Berlin-based clinical contract research organization (CRO) ICRC-Weyer GmbH is adapting a process of integrating medical review procedures into Pharmacovigilance risk management, a method that will lead to better Pharmacovigilance practices.
ICRC-Weyer has made further enhancements to their Pharmacovigilance risk management. By integrating medical review procedures into the Pharmacovigilan ...
ICRC-Weyer GmbH, a clinical contract research organization (CRO) based in Berlin, Germany, has released its review of the year 2012, stating it has been a successful and exciting 12 months for everybody involved in the business. The company looks forward to more constructive partnerships and growth for the year ahead.
The management of ICRC-Weyer GmbH looks back at a successful year 2012, with a number of new collaborations and partnerships in the area of outsourcin ...
The clinical contract research organization (CRO) ICRC-Weyer GmbH, based in Berlin, Germany, has announced that the company is prepared for the increasing number of Advanced Therapy trials, a trend that is expected to continue for the next 10 to 15 years.
ICRC-Weyer's recent participation in the NanoKTN biotechnology meeting in Berlin proved to be both informative and successful. The event which took pl ...